Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer
NCT03795246 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2026-03-18
Summary
Interventional research with low risks and constraints, prospective and monocentric on the assessment of long-term fertility in patients who underwent an adjuvant sequential chemotherapy with or without a controled ovarian hyperstimulation. This study follows a previous one called NCT 01614704.
Conditions
Interventions
- PROCEDURE
-
Consultation
Consultation in oncology: collection of oncological data and ongoing cancer treatments, clinical exam Consultation in gynecology: collection of gynecological data, contraception and reproductive medicine
- BIOLOGICAL
-
Biological Test
Blood test: * FSH, LH, E2 and AMH * 4 tubes of 7 mL
- PROCEDURE
-
Pelvic Ultrasound
Antral Follicles Count
Sponsors & Collaborators
-
Centre Oscar Lambret
lead OTHER
Principal Investigators
-
Audrey MAILLIEZ, MD · Centre Oscar Lambret
-
Christine DECANTER, MD · Centre Hopsitalier Regional Universitaire de Lille - Hôpital Jeanne de Flandre
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-12
- Primary Completion
- 2028-01-31
- Completion
- 2028-01-31
Countries
- France
Study Locations
More Related Trials
-
Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer
NCT01114464 ·Status: TERMINATED
-
Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer
NCT02890082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen
NCT02053597 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3
-
Oocyte Recovery During Tamoxifen Adjuvant Therapy
NCT02355600 ·Status: UNKNOWN
-
AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients
NCT06313476 ·Status: NOT_YET_RECRUITING
-
Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
NCT07127315 ·Status: COMPLETED
-
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients
NCT04536467 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
NCT00330317 ·Status: COMPLETED ·Phase: PHASE3
-
Ovarian Reserve in Premenopausal Breast Cancer
NCT01726322 ·Status: TERMINATED
-
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3
-
A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast Cancer
NCT07180914 ·Status: NOT_YET_RECRUITING
-
Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
NCT05297617 ·Status: RECRUITING ·Phase: PHASE2
-
Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer
NCT03747042 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not
NCT01553903 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer
NCT03946579 ·Status: COMPLETED ·Phase: NA
-
Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)
NCT04289805 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Sexual Quality of Life for Breast Cancer
NCT04200001 ·Status: COMPLETED
-
Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
NCT01072318 ·Status: UNKNOWN ·Phase: PHASE4
-
CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer
NCT02918084 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
NCT00237133 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
NCT05730647 ·Status: ACTIVE_NOT_RECRUITING
-
A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer
NCT07159451 ·Status: RECRUITING ·Phase: PHASE2
-
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
NCT00062400 ·Status: COMPLETED ·Phase: NA